News
Wolfe says SPX could crash if the US economy slides into a recession. Its analyst Chris Senyek warns the S&P 500 could tank ...
3d
Fintel on MSNWolfe Research Downgrades Flywire (FLYW)Fintel reports that on April 23, 2025, Wolfe Research downgraded their outlook for Flywire (NasdaqGS:FLYW) from Outperform to ...
5d
Stocktwits on MSNDisney’s Stock Gets An Upgrade, Wolfe Research Says ‘Castle’ Is Intact Amid Recession RisksWolf Research upgraded Walt Disney (DIS) shares to ‘Outperform’ from ‘Peer Perform’ on Monday, citing durable strengths in ...
2d
24/7 Wall St. on MSNLive Nasdaq Composite: AVGO (Nasdaq: AVGO) Rises, PEP Falls in Mixed Market ShowingLive Updates Live Coverage Has Ended Big Tech Power 3:43 pm by Gerelyn Terzo All three of the major stock market averages are ...
Wolfe Research upgraded Disney (DIS) to Outperform from Peer Perform with a $112 price target The firm says the Disney “castle” is “intact” ...
Fintel reports that on April 21, 2025, Wolfe Research downgraded their outlook for Prologis (WBAG:PRLD) from Outperform to Peer Perform. There are 2,549 funds or institutions reporting positions ...
Wolfe Research’s Peter Supino has downgraded Tokyo-listed shares of Sony Group Corporation’s stock, warning that rising costs and weakening consumer confidence from President Donald Trump’s ...
Investing.com -- Wolfe Research upgraded U.S. Bancorp (BVMF:USBC34) to "Outperform," citing a attractive valuation and expected improvements in operating performance. USB has been the worst ...
It has been a wild stretch for global financial markets, marked by some of the biggest one-day moves of the past decade. Some ...
Shares of Intellia Therapeutics (NASDAQ:NTLA) were up over 10% on Monday, after Wolfe Research upgraded the company to Outperform from Peer Perform.
Fintel reports that on April 21, 2025, Wolfe Research upgraded their outlook for Walt Disney (SNSE:DISCL) from Peer Perform to Outperform. There are 4,576 funds or institutions reporting positions ...
Wolfe Research analyst Joshua Tilton upgraded Varonis (VRNS) to Outperform from Peer Perform with a $50 price target Easily identify stocks' risks and opportunities. Discover stocks' market ...
Results that may be inaccessible to you are currently showing.
Hide inaccessible results